Abstract
Purpose
To investigate the risk factors and the factors affecting surgical and visual outcomes of rhegmatogenous retinal detachment in patients under 40 years of age.
Methods
This retrospective study included 88 patients (96 eyes) diagnosed with rhegmatogenous retinal detachment that were followed up for more than 3 months postoperatively. Patients were categorized into 3 groups according to age. The etiologic risk factors and the primary anatomical and functional success rates were analyzed. Preoperative factors that could affect postoperative visual acuity and primary anatomical outcome, such as subretinal strands and proliferative vitreoretinopathy (grade C or worse), were analyzed.
Results
Myopia more severe than −4.0 diopters was the most common predisposing factor in all 3 groups. Anatomical success rates and functional success rates were not significantly different among the groups. Prevalence of macular detachment and proliferative vitreoretinopathy were highest in group 1. The presence of subretinal strands was highest in group 2 and proliferative vitreoretinopathy was highest in group 1. Patients with preoperative subretinal strands showed a lower primary anatomical success rate in group 1 and poor postoperative visual acuity in groups 1 and 2. Patients with proliferative vitreoretinopathy had poor postoperative visual acuity however there was no significant difference in primary anatomical success rate among the groups.
Conclusions
Proliferative vitreoretinopathy did not affect the anatomical success rate but did affect visual outcome in rhegmatogenous retinal detachment in patients under age 40. Subretinal strands contributed to a lower anatomical success rate and poorer visual outcome in such patients that were under age 18.
References
1. Machemer R. The importance of fluid absorption, traction, intraocular currents, and chorioretinal scars in the therapy of rhegmatogenous retinal detachments. XLI Edward Jackson memorial lecture. Am J Ophthalmol. 1984; 98:681–93.
2. Foos RY. Posterior vitreous detachment. Trans Am Acad Ophthalmol Otolaryngol. 1972; 76:480–97.
3. Akabane N, Yamamoto S, Tsukahara I, et al. Surgical outcomes in juvenile retinal detachment. Jpn J Ophthalmol. 2001; 45:409–11.
4. Han DP, Mohsin NC, Guse CE, et al. Comparison of pneumatic retinopexy and scleral buckling in the management of primary rhegmatogenous retinal detachment. Southern Wisconsin Pneumatic Retinopexy Study Group. Am J Ophthalmol. 1998; 126:658–68.
5. Park JL, Kim SD, Yun IH. A clinical study of the rhegmatogenous retinal detachment. J Korean Ophthalmol Soc. 2002; 43:1015–24.
6. Tani P, Robertson DM, Langworthy A. Rhegmatogenous retinal detachment without macular involvement treated with scleral buckling. Am J Ophthalmol. 1980; 90:503–8.
7. Lusky M, Weinberger D, Ben-Sira I. The prevalence of retinal detachment in aphakic high myopic patients. Ophthalmic Surg. 1987; 18:444–5.
8. Wang Q, Klein BE, Klein R, Moss SE. Refractive status in the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1994; 35:4344–7.
10. Jeong SK, Park YG, Lee MK. A clinical study on rhegmatogenous retinal detachment. J Korean Ophthalmol Soc. 1992; 33:589–98.
11. Han ER, Kang JE, Jun RM, Choi KR. Changes of refractive errors and optometric values in fourth graders at an urban elementary school in Korea. J Korean Ophthalmol Soc. 2007; 48:1119–25.
12. Chang PY, Yang CM, Yang CH, et al. Clinical characteristics and surgical outcomes of pediatric rhegmatogenous retinal detachment in Taiwan. Am J Ophthalmol. 2005; 139:1067–72.
13. Weinberg DV, Lyon AT, Greenwald MJ, Mets MB. Rhegmatogenous retinal detachments in children: risk factors and surgical outcomes. Ophthalmology. 2003; 110:1708–13.
14. Kreiger AE, Hodgkinson BJ, Frederick AR Jr, Smith TR. The results of retinal detachment surgery. Analysis of 268 operations with a broad scleral buckle. Arch Ophthalmol. 1971; 86:385–94.
15. Chignell AH. Retinal detachment surgery without drainage of subretinal fluid. Am J Ophthalmol. 1974; 77:1–5.
16. Chung H, Lee JH. Clinical analysis of retinal detachment. J Korean Ophthalmol Soc. 1978; 19:429–39.
17. Park BG, Cho KI. A clinical study on retinal detachment. J Korean Ophthalmol Soc. 1981; 22:787–98.
18. Jeong SK, Park YG, Lee MK. A clinical study on rhegmatogenous retinal detachment. J Korean Ophthalmol Soc. 1992; 33:589–98.
19. McPherson AR, O'Malley RE, Butner RW, Beltangady SS. Visual acuity after surgery for retinal detachment with macular involvement. Ann Ophthalmol. 1982; 14:639–45.
20. Ranchod TM, Ho LY, Drenser KA, et al. Clinical presentation of familial exudative vitreoretinopathy. Ophthalmology. 2011; 118:2070–5.
21. Gonzales CR, Singh S, Yu F, et al. Pediatric rhegmatogenous retinal detachment: clinical features and surgical outcomes. Retina. 2008; 28:847–52.
22. Stickler GB, Hughes W, Houchin P. Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): a survey. Genet Med. 2001; 3:192–6.
23. Kang SM, Yoon SW, Chin HS, Moon YS. Factors affecting the visual outcome after scleral buckle in rhegmatogenous retinal detachment involving macula. J Korean Ophthalmol Soc. 2007; 48:815–21.
24. Ahmadieh H, Entezari M, Soheilian M, et al. Factors influencing anatomic and visual results in primary scleral buckling. Eur J Ophthalmol. 2000; 10:153–9.
25. Weichel ED, Martidis A, Fineman MS, et al. Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment. Ophthalmology. 2006; 113:2033–40.
26. Yeo JH, Glaser BM, Michels RG. Silicone oil in the treatment of complicated retinal detachments. Ophthalmology. 1987; 94:1109–13.
27. Benson WE, Nantawan P, Morse PH. Characteristics and prognosis of retinal detachments with demarcation lines. Am J Ophthalmol. 1977; 84:641–4.
28. Park CS, Chang WH, Cha SC, Park YH. Surgical results of scleral buckling in retinal detachments with subretinal traction band. J Korean Ophthalmol Soc. 2004; 45:1092–8.
Table 1.
Group 1 (n = 18) | Group 2 (n = 41) | Group 3 (n = 37) | p-value | |
---|---|---|---|---|
Age (years) | 13.78 ± 3.64 | 25.12 ± 3.96 | 35.65 ± 2.55 | |
Sex (M:F) | 14:4 | 20:21 | 22:15 | 0.111* |
Duration of symptoms (days) | 66.22 ± 112.30 | 39.78 ± 94.43 | 62.81 ±122.79 | 0.230† |
BCVA at first visit (log MAR) | 1.12 ± 0.77 | 0.86 ± 0.84 | 0.61 ± 0.87 | 0.012†,‡ |
BCVA at final visit (log MAR) | 0.70 ± 0.81 | 0.51 ± 0.66 | 0.31 ± 0.56 | 0.087† |
Subretinal strands (%) | 6 (33) | 18 (43) | 10 (27) | 0.292* |
PVR (%) | 14 (78) | 14 (33) | 13 (35) | 0.004*,‡ |
Macula off (%) | 13 (72) | 19 (46) | 13 (35) | 0.035*,‡ |
Predisposing factor (%) | ||||
Myopia | 10 (56) | 27 (64) | 23 (62) | 0.062* |
Lattice degeneration in myopic eye | 5 (50) | 16 (59) | 14 (61) | 0.837* |
Trauma | 1 (5) | 2 (5) | 1 (3) | 0.845* |
Old RD | 0 (0) | 1 (2) | 3 (8) | 0.282* |
Uveitis | 1 (5) | 1 (2) | 4 (11) | 0.10* |
Refractive surgery | 0 (0) | 2 (5) | 1 (3) | 0.787* |
Cataract surgery | 3 (17) | 2 (5) | 0 (0) | 0.08* |
Table 2.
Subretinal strands |
p-value* |
PVR |
p-value* | ||||
---|---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | ||||
Group 1 | Initial BCVA | 1.98 ± 0.86 | 0.84 ± 0.51 | 0.042† | 1.23 ± 0.86 | 0.80 ± 0.32 | 0.517 |
Last BCVA | 1.70 ± 1.02 | 0.37 ± 0.37 | 0.004† | 0.88 ± 0.87 | 0.15 ± 0.19 | 0.047† | |
Group 2 | Initial BCVA | 1.00 ± 0.87 | 0.74 ± 0.82 | 0.310 | 1.62 ± 0.80 | 0.46 ± 0.54 | <0.001† |
Last BCVA | 0.77 ± 0.73 | 0.30 ± 0.52 | 0.005† | 1.04 ± 0.66 | 0.22 ± 0.46 | <0.001† | |
Group 3 | Initial BCVA | 0.74 ± 1.04 | 0.57 ± 0.82 | 0.553 | 1.15 ± 1.02 | 0.34 ± 0.65 | 0.002† |
Last BCVA | 0.23 ± 0.34 | 0.34 ± 0.62 | 0.974 | 0.62 ± 0.84 | 0.15 ± 0.22 | 0.011† |
Table 3.
Table 4.
Primary success rate | Group 1 (n = 18) | Group 2 (n = 41) | Group 3 (n = 37) | p-value* |
---|---|---|---|---|
Anatomical (%) | 14 (78) | 36 (88) | 32 (86) | 0.396 |
Functional (%) | 8 (45) | 24 (59) | 26 (70) | 0.175 |
Table 5.
Buckle (n = 61) | PPV (n = 20) | PPV + buckle (n = 15) | p-value | |
---|---|---|---|---|
Age (years) | 28.00 ± 6.89 | 30.89 ± 8.74 | 18.88 ± 10.07 | 0.001†,‡ |
Primary anatomical success rate (%) | 55 (90) | 15 (75) | 13 (87) | 0.237* |
Primary functional success rate (%) | 38 (62) | 12 (60) | 6 (40) | 0.264* |
Pre-operative BCVA | 0.45 ± 0.58 | 1.11 ± 1.03 | 1.28 ± 0.61 | <0.001†,‡ |
Final BCVA | 0.20 ± 0.34 | 0.44 ± 0.46 | 0.71 ± 0.55 | <0.001†,‡ |